Clinical Trial Update: MINERVA: MINimizE Right Ventricular Pacing to Prevent Atrial Fibrillation and Heart Failure [Phase 4]

View source ↗

Summary

Phase 4 MINERVA trial assessed whether minimizing right ventricular pacing can prevent atrial fibrillation and heart failure. Results were completed and posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Heart Failure

Drugs mentioned

• Right ventricular pacing therapy (cardiac pacing device)

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Atrial Fibrillation, Heart Failure, Congestive | Phase 4 | Status: COMPLETED | Results posted: 2014-06-11